Skip to main content

Advertisement

Log in

Survivin as a Target for Anti-cancer Phytochemicals According to the Molecular Docking Analysis

  • Published:
International Journal of Peptide Research and Therapeutics Aims and scope Submit manuscript

Abstract

Survivin is a unique member of the inhibitor of apoptosis protein family. Research has approved Survivin’s ability to interact with Smac/DIABLO, suggesting that Survivin may suppress activation of caspases indirectly. On the other hand, research has demonstrated that many drugs for cancer therapy are unsuccessful and disappointing in advanced stages. Therefore, it is necessary to find new drugs with the highest anti-cancer properties and lowest side effects. We investigated the interaction of some phytochemicals with BIR domain of Survivin. In this study, the 3D structures of some phytochemicals, including Berberine, Carvacrol, Crocetin, Crocin, Curcumin, Picrocrocin, Piperine, and Thymol, were harnessed from Human Metabolome Database, which has reported some evidence about these phytochemicals’ anti-cancer effect via the apoptosis induction with Survivin. Then, these structures were prepared for molecular docking analysis by Autodock Vina software. Ultimately, the binding energies between docked Survivin and the above mentioned phytochemicals were calculated and their interactions were predicted. Our results indicated that all phytochemicals can interact with Survivin molecule in active site of Smac/DIABLO and the best minimum binding energies belong to Piperine and Picrocrocin. It is concluded that, out of the studied compounds, Piperine and Picrocrocin could act as potential inhibitors of Survivin.

Graphic Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

Download references

Acknowledgements

This study was supported by Grant No 9775 from Shahroud University of Medical Sciences.

Funding

This study was funded by Shahroud University of Medical Sciences (Grant No 9775).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Moslem Jafarisani or Mersedeh Tashakori.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors. However, we have ethical cod approve IR.SHMU.REC.1397.112 by ethical committee of SHMU.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Foroughi, K., Jahanbani, S., Nazarnezhad, S. et al. Survivin as a Target for Anti-cancer Phytochemicals According to the Molecular Docking Analysis. Int J Pept Res Ther 26, 1115–1126 (2020). https://doi.org/10.1007/s10989-019-09914-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10989-019-09914-3

Keywords

Navigation